New England Research & Management’s Axalta AXTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-23,425
Closed -$518K 160
2022
Q2
$518K Buy
23,425
+550
+2% +$14K 0.3% 106
2022
Q1
$562K Sell
22,875
-650
-3% -$18.2K 0.29% 98
2021
Q4
$779K Buy
+23,525
New +$746K 0.38% 81
2019
Q2
Sell
-10,000
Closed -$252K 164
2019
Q1
$252K Sell
10,000
-1,200
-11% -$30.9K 0.17% 144
2018
Q4
$262K Sell
11,200
-3,700
-25% -$91.9K 0.21% 129
2018
Q3
$434K Sell
14,900
-5,600
-27% -$168K 0.28% 109
2018
Q2
$621K Hold
20,500
0.41% 95
2018
Q1
$619K Buy
+20,500
New +$641K 0.41% 89
2017
Q4
Sell
-10,400
Closed -$301K 154
2017
Q3
$301K Buy
+10,400
New +$314K 0.22% 115
2017
Q1
Sell
-13,150
Closed -$358K 161
2016
Q4
$358K Buy
+13,150
New +$346K 0.28% 122

Other funds holding AXTA

New England Research & Management's AXTA Position: Q3 2022 in Review

New England Research & Management sold out of Axalta (AXTA) in Q3 2022, closing a stake of 23,425 shares — an estimated $518K sold.

New England Research & Management first reported a position in AXTA in Q4 2016 and held it in 10 quarters. The position peaked at $779K in Q4 2021. 278 funds tracked by Wall St. Rank hold AXTA as of Q3 2022.

  • New England Research & Management reported no remaining Axalta position as of Q3 2022 after selling out during the quarter.
  • New England Research & Management sold 23,425 Axalta shares in Q3 2022, an estimated $518K.
  • New England Research & Management first reported a position in Axalta in Q4 2016 and held it in 10 quarters.
  • New England Research & Management's Axalta position peaked at $779K in Q4 2021.
  • 278 funds tracked by Wall St. Rank held Axalta as of Q3 2022.

Based on New England Research & Management's 13F filing for Q3 2022, filed 6 Oct 2022.